- Raised $1.4M funding round, Jul 2023
- Raised $1M funding round, Feb 2021
- Raised $1M funding round led by Israel Innovation Authority, May 2019
About
Regenyx Medical is redefining minimally invasive soft tissue restoration—a cornerstone of plastic and reconstructive surgery. Our lead product, Lipogenyx, is the first fat viability extender: a next-generation fat grafting solution that enhances graft survival and integration, enabling natural-looking, lasting and predictable results in reconstructive and aesthetic procedures. Built on a proprietary synthetic peptide hydrogel technology, Lipogenyx offers a scalable, potentially reimbursable platform that eliminates the need to revision fat grafting procedures and streamlines physicians efficiency and patient satisfaction. Selected for the 2025 MedTech Innovator and ASPS Top 5 Innovation Track, Regenyx is now preparing for its first clinical study and establishing U.S. operations.
Funding history · 3 rounds · $3.4M total
Q&A
- What is Regenyx Medical's primary focus?
- Regenyx Medical is focused on redefining minimally invasive soft tissue restoration, particularly through matrix-enhanced fat grafting.
- What is Regenyx Medical's flagship product?
- Regenyx Medical's lead product is Lipogenyx, a fat viability extender designed to enhance graft survival and integration in reconstructive and aesthetic procedures.
- What technology is Lipogenyx built upon?
- Lipogenyx is built on a proprietary synthetic peptide hydrogel technology.
- When was Regenyx Medical founded?
- Regenyx Medical was founded in November 2016.
- How many employees does Regenyx Medical have?
- Regenyx Medical has 1-10 employees.
- What is Regenyx Medical's total funding to date?
- Regenyx Medical has raised a total of $3.4 million USD.
- When was Regenyx Medical's most recent funding round?
- Regenyx Medical's most recent funding round occurred in July 2023, raising $1.4 million USD.
- Which investor participated in Regenyx Medical's May 2019 funding round?
- The Israel Innovation Authority participated in Regenyx Medical's May 2019 funding round.
- What is Regenyx Medical's current product stage?
- Regenyx Medical's product is currently in the clinical trial stage.
- What recognition has Regenyx Medical received recently?
- Regenyx Medical was selected for the 2025 MedTech Innovator and ASPS Top 5 Innovation Track.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | regenyxmed.com/ |
|---|---|
| linkedin.com/company/102185269 |
Identifiers & details
| Former names | Bone Sci. Bio Ltd. |
|---|---|
| Founded | 2016-11 |
| Employees (exact) | 6 |
Radar intelligence
Web history (Wayback)
| Domain | regenyxmed.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|